R&D Specialist (Oncolytic Viruses)
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Tarrytown, New York, United States of America
- Start date
- Jul 30, 2021
View more
- Discipline
- Clinical, Clinical Medicine, Science/R&D, Virology
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
As an R&D Specialist, a typical day may include the following:
- Conduct in vivo tumor studies with oncolytic viruses
- Process tissue for RNA based assays (qPCR, RNAseq) and IHC
- Design and analyze qPCR assays
- Perform and troubleshoot in vitro virological assays
- Clone and generate viruses
- Generate cell lines with CRISPR and/or lentivirus transduction
- Maintain and culture cells as necessary
This role may be for you if:
- You are adaptable and have the ability to change tasks as needed
- You enjoy working in a fast-pace environment and have the ability to multi-task and learn new techniques
To be considered for this role, you must have a MS + 2 year of experience or a BS + 5 years of experience. At least a year of experience with animal work is also required. Experience with animal studies, particularly with tumor models. Basic proficiency in molecular biology and cell culture are also required. Preferred to have experience in virology, handling infectious agents, qPCR, cloning, IHC/microscopy, and/or other molecular biology techniques.
Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert